Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.60
+0.06 (0.80%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $413.18 million as of April 24, 2025. Its market cap has decreased by -81.40% in one year.
Market Cap
413.18M
Enterprise Value
319.36M
1-Year Change
-81.40%
Ranking
Category
Stock Price
$7.60
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $413.18M, a decrease of -81.07%. That is a compound annual growth rate of -33.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 413.18M | -20.74% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.15B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |